North America Leads the Intravitreal Injection Market
North America leads the Intravitreal Injection Market, driven by high retinal disease prevalence, advanced ophthalmology infrastructure, and rapid adoption of anti-VEGF therapies. The US has one of the highest rates of AMD and diabetic retinopathy globally, and its healthcare system supports widespread use of intravitreal injections. Europe follows closely, supported by strong public health...
0 Yorumlar 0 hisse senetleri 17 Views 0 önizleme